Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Xiaoyi Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9714-3467; OpenAlex author ID A5100442797, A5140619029. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. HRD Score: A Promising Biomarker for Genomic Instability Evaluation for Targeted Treatments Among Pancreatic Cancer Patients. Co-author DOI 10.1177/15330338261469099↗
  2. Single-nucleotide polymorphisms based genetic risk score in the prediction of pancreatic cancer risk. Co-author DOI 10.3748/wjg.v26.i22.3076↗
  3. An evaluation study of reported pancreatic adenocarcinoma risk-associated SNPs from genome-wide association studies in Chinese population. Co-author DOI 10.1016/j.pan.2017.09.009↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baian Tao · 1 shared paper, 2026 · strength 0.33
  2. Deliang Fu · 1 shared paper, 2026 · strength 0.33
  3. Jianfeng Xu · 2 shared papers, 2017–2020 · strength 0.18
  4. Chen Jin · 2 shared papers, 2017–2020 · strength 0.18
  5. Deliang Fu · 2 shared papers, 2017–2020 · strength 0.18
  6. Haitao Chen · 1 shared paper, 2020 · strength 0.11
  7. Ji Li · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.